Dennis Slamon

9PUBLICATIONS
128CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersMolecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 03, 2026
Inhibition of Acetyl-CoA-carboxylase induces endoplasmic reticulum stress and augments the efficacy of anti-cancer therapies.

|Sep 17, 2025
Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence.

Fabio Conforti, Federico Merlo, Laura Pala

|Feb 28, 2025
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial.

Peter A Fasching, Dennis Slamon, Zbigniew Nowecki

|Sep 30, 2024
Early Detection of Ovarian Cancer Using Cell-Free DNA Fragmentomes and Protein Biomarkers.

Jamie E Medina, Akshaya V Annapragada, Pien Lof

|Jan 22, 2024
Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer.

Dennis J Slamon, Véronique Diéras, Hope S Rugo

|Oct 03, 2023
Development of a Novel CLDN18.2-directed Monoclonal Antibody and Antibody-Drug Conjugate for Treatment of CLDN18.2-Positive Cancers.

Neil A O'Brien, Martina S J McDermott, Jun Zhang

Pageof 2

Frequent Collaborators

3 joint publications

Martina S J McDermott

3 joint publications

John Glaspy

3 joint publications

Neil O'Brien

2 joint publications

Tong Luo